Download PDF
Thromb Haemost 1998; 79(04): 884
DOI: 10.1055/s-0037-1615087
Letters to the Editor
Schattauer GmbH

What Is the Tasman Trial?

Tsung O. Cheng
1   The George Washington University, Washington, DC, USA
› Author Affiliations
Further Information

Publication History

Received 13 November 1997

Accepted 14 November 1997

Publication Date:
07 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Graafsma YF, Prins MH, Lensing AWA, de Haan RJ, Huisman MV, Büller HR. Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost 1998; 78: 1189-92.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Koopman MMW, Prandoni P, Piovella F. et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334: 682-7.
    CrossrefPubMedGoogle Scholar
  • 3 International Committee of Medical Journal Editors.. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1991; 324: 424-8.
    CrossrefPubMedGoogle Scholar
  • 4 Cheng TO. Acronym aggravation. Br Heart J 1994; 71: 107-9.
    CrossrefPubMedGoogle Scholar
  • 5 Cheng TO. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice. Cardiology 1996; 87: 267.
    CrossrefPubMedGoogle Scholar
  • 6 Cheng TO. Acronymophilia: the exponential growth of the use of acronyms should be resisted. Br Med J 1994; 309: 683-4.
    CrossrefPubMedGoogle Scholar